Dr Carol Russ, PHD | |
1767 Grand Ave, Suite 4, Pacific Beach, CA 92109-4400 | |
(858) 755-8206 | |
Not Available |
Full Name | Dr Carol Russ |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 1767 Grand Ave, Pacific Beach, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1770577991 | NPI | - | NPPES |
PSY6070 | Other | CA | CLINICAL PSYCHOLOGIST |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PSY6070 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Carol Russ, PHD 1767 Grand Ave, Suite 4, Pacific Beach, CA 92109-4400 Ph: (858) 755-8206 | Dr Carol Russ, PHD 1767 Grand Ave, Suite 4, Pacific Beach, CA 92109-4400 Ph: (858) 755-8206 |
News Archive
Ischemic stroke patients who arrive at the hospital too late to receive currently available treatment options might someday have a new treatment option. Northwestern Memorial Hospital is the only site in Chicago to participate in a phase III trial of abciximab (ReoPro - Centocor/Eli Lilly and Company), which seeks to determine the drug's ability to improve neurological function and minimize disability in patients who present with an acute ischemic stroke.
As the treatment of severe COVID-19 is very difficult, the researchers from the Korea Research Institute of Biosciences and Biotechnology (KRIBB) suggested that DNase-1 can be utilized to dissolve the neutrophil extracellular traps (NETs), hence halting the further progression of COVID-19.
The 18th Keio Medical Science Prize has been awarded to Victor R. Ambros, PhD, professor of molecular medicine at the University of Massachusetts Medical School and the Silverman Chair in Natural Science; and Shigekazu Nagata, PhD, professor of medical chemistry in the Graduate School of Medicine at Kyoto University.
The results of a new Pharma Insight study released today by Wolters Kluwer Pharma Solutions, Inc., a leading provider of scientific information and analytics to the pharmaceutical and biotech fields, is not exactly what the doctor ordered. The company's annual analysis of the U.S. pharma market suggests that the economy has led to increased patient participation in decisions about prescription drugs.
In roughly one-third of pancreatic cancer patients, tumors have grown around the pancreas to encompass critical blood vessels. Conventional wisdom has long held that surgery to remove the tumors is rarely an option, and life expectancies are usually measured in months.
› Verified 2 days ago